The Conversation (0)
Matica Enterprises Inc. (CSE: MMJ) (FSE: 39N) (OTCQB: MMJFF) ("Matica" or the "Company") is pleased to announce that Matica subsidiary RoyalMax Biotechnology Canada Inc. ("RoyalMax") has received approval to supply cannabis from the Saskatchewan Liquor and Gaming Authority (SLGA), the provincial regulator responsible for permitting and monitoring the operation of local cannabis wholesalers and retailers in the Province. As a newly registered supplier for the Province of Saskatchewan, the Company looks forward to commencing retail sales.
"We are excited that Saskatchewan will be the first province to try our premium Montreal cannabis," says Matica CEO, Boris Ziger. "In short order we will be opening up sales in other provinces as well."
This a major milestone for Matica and RoyalMax. The Company is completing its transition to a commercial, revenue generating enterprise. Generating revenue and profits for our shareholders is a priority for management at this time, as is growth. Over the coming months we will be re-evaluating projects and introducing new ones. Please go to Matica's website for more news and follow us on Twitter for articles and updates.
The Company has granted 10,250,000 stock options including 9,000,000 to one consultant and two directors, which included reissuing of 7,000,000 million previously cancelled options. A further 1,250,000 were granted to three consultants. All granted options are exercisable at $0.025 for up to five years from the date of grant. Further, the Company has cancelled 3,000,000 previous granted management stock options.
For more information on Matica Enterprises please visit the website at: www.maticaenterprises.com.
On behalf of the Board of Directors
Matica Enterprises INC.
Boris Ziger
Boris Ziger, CEO & Chairman
The Company's public filings are available for review at www.sedar.com and www.thecse.com.
For further information, please contact Boris Ziger, at:
Telephone: 416-304-9935
E-mail: info@maticaenterprises.com
Website: www.maticaenterprises.com , www.maticammj.com
Disclaimer for Forward-Looking Information
Certain information in this press release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Corporation assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Corporation. Additional information identifying risks and uncertainties is contained in the Corporation's filings with the Canadian securities regulators, which filings are available at www.sedar.com.
This news release contains statements about the Company's information that may be made available on the S&P Capital IQ Corporation Records Listing Program and the business of Matica that are forward-looking in nature and as a result, are subject to certain risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, undue reliance should not be placed on them as actual results may differ materially from the forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof, and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, except as required by law.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. We seek Safe Harbor.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/67304
